Information & Resources

Find information and resources to help manage your pain.

Get Help & Support

Find the tools you need to
help you manage your pain.

Get Involved

Help make a real difference to people
in the UK living with chronic pain.

About Us

Find out about Pain Concern and how
we can help you.

Over the next few weeks you’ll hear from Andy Jeffrey, one of our volunteers. Andy’s almost 40 and lives in Edinburgh. Through his writing, he hopes to help others by sharing how he has rebuilt his life following a diagnosis of a chronic pain condition. By way of introduction, we asked him a few questions

A smiling Andy Jeffrey, with glasses and a red beard takes a selfie in front of the Eiffel Tower. The photo is taken from a low angle, capturing the intricate ironwork structure of the iconic landmark against a clear sky. He is wearing a green hoodie and a backpack.

How would you introduce yourself?

Navigating life with my fibromyalgia, Borderline Personality Disorder and suspected autism. 

That’s a lot. What keeps you inspired?

Coaching, writing and football analysis. Also, I am a proud dad to Ailidh who is 4 and keeps me going day in, day out. 

You attended a pain management programme at Astley Ainslie Hospital, Edinburgh. Tell us about that.

I learned to build a new life around my condition. One that doesn’t mean giving up on the things I love but rather finding new ways to engage with them. I’ve learned to pace myself, to listen to my body and to prioritize self-care in ways I never had to before.  

Why is writing important to you?

It’s allowed me to connect with others. Learning that I’m not alone, that others understand the unique struggles of this condition, has been incredibly validating. We share tips, offer encouragement, and remind each other that while chronic pain is part of our lives, it doesn’t define who we are. 

What else would you like to share?

My journey through chronic pain, mental health and self-discovery. Let’s connect, learn and grow together.  

Welcome to Pain Concern. 


See more of Andy’s writing about his other great passion:

Resources

Peer Support. Join the community

“Having chronic pain is very lonely.”

Join the community

Subscribe to Pain Matters

Everything you need to know about how to live with chronic pain

Subscribe

 

 

In pain? Don’t understand what’s happening?

“Having someone to help you prepare for your life through pain”

Our Pain Education Sessions

Fundraise for Pain Concern

Help us to help others

Fundraise

 

Beth Evans in conversation with Jason Wilsher-Mills

Jason Wilsher-Mills is an artist from Wakefield. His exhibition ‘Jason and the adventure of 254’ is being shown at the Wellcome Collection until 12 January 2025. At the age of eleven, Jason was diagnosed with an autoimmune condition that paralysed him from the neck down. The doctors told Jason’s parents that he would not live to the age of sixteen. He was diagnosed at 2:54pm on 1 August 1980, as he watched the 1500m men’s race at the Moscow Olympics in which British athlete Seb Coe won the race bearing the number 254.  

Now, over forty years later, Jason reflects on the year he lived in Pinderfields Hospital. Encapsulating what it was like becoming disabled as a child, he has created a space filled with nostalgia, magical realism and creativity. 

I was lucky enough to sit down with Jason and ask him all about his exhibition, his inspirations and how art can be used as a creative outlet for pain and disability.  

Early Life and Artistic Vision

Could you introduce yourself and tell me a bit about your exhibition and the inspiration behind it? 

My name is Jason Wilsher-Mills. I’m an artist who creates work about disability and childhood trauma. I do it in a way that’s kind of humorous because in my head I pretend that I’m working for The Beano in the 1970s and I’ve gone down a Marxist activist route, producing content for them about disability. 

So, all the work that I create is influenced by that working-class aesthetic from the 1970s, growing up in a council estate and watching lots of telly. It’s also about being bright and interested in ideas and subsequently becoming disabled at the age of eleven. My work is psychically landlocked in childhood. It’s about those issues of how one deals with and navigates illness. And in my case, it was apparently terminal. I wasn’t supposed to be around. And here I am, an old fart looking like Uncle Albert from Only Fools and Horses.  

Quote from Jason Wilsher-Mills - "I wasn't supposed to be around. And here I am, an old fart looking like Uncle Albert from Only Fools and Horses"

Creating a Child’s Wonderland

Stepping into the exhibition space really feels like you’re stepping into a child’s imagination. The bright colours and the magical realism make it such a playful atmosphere in comparison to a stereotypical hospital ward. Was this at the centre for you when you began your work on this exhibition? 

First of all, when the Wellcome Collection approached and said, ‘would you like an exhibition with us’, it was the most exciting thing I’d ever heard. When they showed me the space, it was long and thin and I thought, ‘this is a hospital ward’. There’s a drawing in the sketchbooks that I did literally on the day I saw that space. I drew what the exhibition would look like. I knew what it was going to be: this huge diorama that was about both the exterior and interior. The exteriors were all the medical stuff, and the interiors were all the memories and things that I thought about in hospital.   

I wanted it to be like the seaside as well. A lot of my work is about these memories of going to the seaside because it was the only time that we saw colour. It was our art galleries. We saw rides with paintings on; it’s the first time I ever saw a painting. I thought, ‘oh blimey! Someone did that!’ There must be people like me that do this job. The exhibition is full of stuff that I remember from that time. I wanted it to be like the kid’s annuals that we used to get at Christmas. 

I wanted facts on the wall, so there’s facts about my chickenpox, which developed into this thing. Then underneath that, I’d put that it was Tom Baker’s last episode or that I heard ‘Strawberry Fields’ for the first time and all these little silly things that create a kind of atmosphere. 

The Significance of 254

The title of your exhibition is ‘Jason and the adventure of 254’. Can you expand on the reasons for that title? 

I’m named after Jason, from Jason and the Argonauts, which is pretty cool. Regarding the 245, I was diagnosed 1 August 1980, between 2:45 and 3:15pm. I know that because it was visiting time at the hospital and I was watching the men’s 1500m race final at the Moscow Olympics. The race started; I think it was about 2:50pm. So I was watching it as I was being diagnosed. The shirt that Seb Coe (British athlete and subsequent winner of the race) was wearing in that very race was the number 254 and I was diagnosed at 2:54pm. 

What are the chances of me being an eleven-year-old kid lying in bed watching this race, getting diagnosed and hearing that I’m not going to make it to the age of sixteen, then forty years forward in time making art about that?

Interactive Art and Accessibility

The exhibition greatly encourages visitors to touch and engage with the exhibition. This is very different to what is stereotypically experienced in art galleries and exhibitions and made for a welcome change. How important was it to you whilst constructing the pieces that your audience should physically touch and engage with your art? 

It was important because I wanted it to be like a fun fair. I want people to have an experience. I want it to be kind of high art. But I knew children would like it and really get it, which is being proven right. I got a lovely e-mail from a parent who said, ‘my kid saw your exhibition two weeks ago and we’re here again because they wanted to come back’. That’s been really powerful. The stuff that I talk about is difficult to talk about; if you’re getting people to engage with it in a sensuous way, in terms of touching it, they start to look at the detail. 

I was in bed for more or less a year, and I couldn’t feel anything in my body other than pain. It was very difficult having this body that was really working against me. It’s an exhibition that’s about trauma, childhood trauma. And I’ve managed to make it entertaining.  

When people are touching it, they’re engaging with me as an eleven-year-old kid. I go to galleries where you see Veneer’s and Rembrandt’s and there’s a distance. Like I said, my main influence as a kid was that I didn’t see art. Instead, I saw fairground rides with paintings on, so I want to make my work about fun. That is the vehicle that I have my own narrative with. 

Scale and Symbolism

You really play with size. The imposing presence of the figure in the bed dominates the space. The calliper boots tower over you. The caricatures of infection are huge, their shadows blocking out the light at parts. The soldiers too are larger than life. The size of Seb Coe with a TV for a head is much smaller in comparison. What was the purpose behind this? 

I was trying to depict the sensory part of a time when I couldn’t feel my body anymore. Yet every now and again I would get really intense signals in my feet, so I increased the scale of the feet. I’m OK messing about with scale and it fits in with a child’s view of things as well. To me, that ward was vast and endless and scary and so I wanted it to be like the seaside as well. 

The boots were influenced by Tommy from The Who. I had to wear those calliper boots. A number of parents have come up to me and said that their kid had to wear them, and they had to paint the boots to make the kid them wear them.  

I mean, every part of me had something attached to it. I had a surgical collar that started at the back of my skull and went all the way down my back. It used to give me really bad migraines. I had a spinal corset, a big thing that strapped me into my chair, so I didn’t fall over. 

I don’t think I’m ever going to be short of ideas as an artist because of my experiences. I was wanting to take these horrible sorts of surgical stuff and make them kind of relatable and accessible. 

Yorkshire Roots and Working-Class Identity

I really enjoyed the way you weaved your working-class roots into your exhibition. I particularly loved the parts of it that read like a love letter to 1970s Yorkshire, especially your colourful depictions of your time at Withernsea on family holidays. How important is this idea of ‘home’ to you in your work? Do you see Yorkshire as its own motif in this exhibition? 

Yorkshire is a bizarre place. They like being forthright: when I got ill, a family member said, ‘well, I’m not going to bloody treat you any differently’.  

I’m one of eight with no money from a little council house and we used to go on holiday to Withernsea, which is a little dot on the east coast of England. It was always bloody freezing and we stayed in this little, we called it a chalet, but it wasn’t, it was a hut. And I thought it was magic.  

As a family, we never articulated anything. We never told each other we loved each other and we never hugged. But you know what? I never ever as a kid thought that I’m not loved. I was so loved. It’s not everybody’s experience but I was really loved, and I was very lucky. My mum, bless her, had her own struggles throughout life. When I told her that I wanted to be an artist, she said, ‘well, if you want to become an artist, we’ll save up and send you to Paris because that’s where they all are’. That was an example of the kind of support that I had.  

The day that I got diagnosed, they were very obviously affected. But my mum said, ‘we’re not going to treat you any differently. We’re going to give you all the best opportunities’. I attended a hospital special school. You’d get in and go ‘where’s Phil?’ and they’d say, ‘he died last week’. That was normal. You had to kind of deal with that quickly and get around it. I’ll tell you, the reunions are nothing to talk about. I’m the only one left. But yeah, it was a very special, fantastic childhood. 

The hospital bit was tough. There are some references in the work that are about quite dark things: I was in hospital for a year and in that period horrible things happened. I’m trying to deal with that as well. The Wellcome Collection have been amazing. They paid for counselling because they said, ‘this seems like it could be quite triggering’. They were proved correct. My sister said, ‘oh, can you remember that time we came to visit you and your head was face-down in your food?’. I couldn’t lift it up, so I’d fallen into my own food. I said ‘no, but thank you for telling me’. 

I think the exhibition has been good because it’s helped people deal with their own experiences. You’re never alone. If you make a piece of artwork that’s a film or a book or whatever, you’re not interrupting: it’s there and people can bring their own experiences to it and bathe in that empathy. And it seems to be working. 

The Power of Maternal Love

Could you tell me a little more about how important your relationship with your mother was in those early years of diagnosis? 

I secretly think that my Yorkshire working-class family was actually Italian because it was all about the Mama. Picasso talks about the Madonna, and I always saw my mum as this kind of beautiful, Madonna type. My mum was really amazing. So was my dad. My dad was really stressed, but he had eight kids and no money, so who wouldn’t be.  

We were brought up really well and we had great experiences. When mum was in her last days, I said to her, ‘thank you’. There were loads of pressure put on them for me to go into a home, which would have killed me. I said, ‘you saved my life, mum’. She said, ‘well, what do you expect me to do? You’re my lad’. 

I’ve always thought that those are such simple words, but it’s words that make governments fall and totally eclipse power. She was Irene. 

Irene and Peter, they were just ordinary people. They both were unbelievably eccentric. My dad would go out of the room and change his hairstyle and come back in and see if anybody had noticed. We laughed all the time.  

And when I was in hospital, I was eleven and my mum was fifty-two. So, she was lifting me in and out of bed in the morning and buying me paints and she was just an incredible woman. I think with working-class families there’s a myth that it’s patriarchal. It’s not, it’s about the mum, it’s about Mama. She was a character. 

Capturing Wonder Through Nostalgia

Nostalgia is peppered into the exhibition, whether that’s your own nostalgia of your youth and time at the hospital or the nostalgia of Britain. Can you tell us a little more on why you emphasise this sense of nostalgia in your pieces? 

When I was first asked about the show, the Wellcome Collection said, ‘what do you want people to think of it?’. I said, ‘I want kids, when they walk in, to go “wow”’. I want adults to remember what it felt like to be a child and to enjoy being playful again.  

Quote from Jason Wilsher-Mills - "I want kids, when they walk in, to go “wow”’. I want adults to remember what it felt like to be a child and to enjoy being playful again."

The dioramas are based on these diorama machines that you used to put twopence in. These 1930s dioramas were rubbish, but I thought they were beautiful. I tracked down the ones that I saw as a kid. They’re in the Hull Streetlife Museum. I found them and I put some money in and I watched them and I was transported back. So, I wanted that sense of wonder, and I wanted people to go inside my memories.  

One of my memories in one of the dioramas was of my mum. She didn’t like swimming in front of people, so we used to go down to the beach at about ten at night. This particular year there was loads of jellyfish. The sea was lit up and there was my little mum, because she was only about five-foot, swimming. When you’re a kid, you’re bright and you feel things intuitively, but you can’t articulate it. I was experiencing this moment, almost thinking to myself, ‘oh, I’ll put this away in the filing cabinet because I think something special is happening here’. You know, we’ve all got stories to tell.  

Personal Healing Through Art

You said that the exhibition very much encapsulates that merging of past and present. Now we are in the ‘future’ of this exhibition. How has this exhibition helped you with reflecting on your time in hospital and the years that followed? 

It has really helped. I’ll be honest, it’s unlocked a lot of memories that I didn’t know I had. It’s helped my family to deal with a lot of stuff. I think it’s helped people that have been to the exhibition to understand illness, childhood illness, and kids get it because it’s funny. There’s a lot of colour there, there’s a lot of humour. 

But you can still be sophisticated and tell stories. I always try and equate it to the film Jaws. The only person who could make Jaws so amazing is Steven Spielberg. If it had been directed by a lesser director, it wouldn’t be the same film. It’d just be like a gorefest. To tell a story, you must have the tools and the ability to be authentic and be real, because people do get it. 

An actress contacted me who knew the director of Inseminoid (a film referenced in one of the dioramas). She said that he was such a nice man and that he’d have approved. She found it very touching.

Art as a Transformative Force

How would you say that art has changed your life? 

From being a working-class kid with no discernible options, it gave me options. It introduced me to education and books.  

It’s taken me a long time because even when I graduated from a fine art degree, I still wasn’t convinced that I was good enough. I became a teacher and then I went into management. It wasn’t until my 30s that I thought I could do this. I call it being fully baked. You’ve been in the oven and now you’re ready to go. Doing a fine art degree was like cultural national service. It introduced me to ideas about politics. I remember going to see The Last Temptation of Christ and all these protesters outside were saying ‘God loves you’ because it was controversial, but we were encouraged, because of the way the art education was then, to look at stuff that was difficult. Instead of going through that door, I went through that door and it gave me that choice; I can choose to do this because I’ve got this education now. 

I’m moving my hands now. It is amazing to be able to do that. Of course, because of the damage done to me whilst being paralysed, I’m now in constant pain. In the middle of this interview, I took some pain medication. It’s making talking a little bit more difficult, but it’s to keep the pain levels down. But there’s so many stories to tell: I see almost a trilogy of future exhibitions ahead because I went from basically being completely paralysed to going to university. I’m also coming to terms with the fact that, oh, I’m not dead.  

I’m alive. 

Editor: Megan Hayes.
© Jason Wilsher-Mills and Pain Concern, 5 December 2024.
All rights reserved.

Beth Evans is arts editor with Pain Concern.

The Wellcome Collection is a museum and library located at 183 Euston Road, London. It is open 10:00am–6:00pm. Entry is free. ‘Jason and the adventure of 254’ has been running since 21 March 2024, and will close 12 January 2025.

More details can be found on the Wellcome Collection’s website, including images of the exhibition’s highlights and a five-minute video tour narrated by Jason.

Resources

Peer Support. Join the community

“Having chronic pain is very lonely.”

Join the community

Subscribe to Pain Matters

Everything you need to know about how to live with chronic pain

Subscribe

 

 

In pain? Don’t understand what’s happening?

“Having someone to help you prepare for your life through pain”

Our Pain Education Sessions

Fundraise for Pain Concern

Help us to help others

Fundraise

 

This episode of Airing Pain focuses on person-centred care. Person-centred care is based on the individual rather than on a generic group of patients.  

In this episode: 

  • Vicky Sandy-Davis, Lead Nurse of Independent Health and Social Care, talks about the importance of recognizing the value of person-centred care, specifically for people with intellectual or learning disabilities 
  • Ian Taverner and Sarah Harrisson discuss the importance of involving people living with chronic pain in research studies so that researchers can be guided by those with experience of chronic pain 
  • Professor Nicole Tang and Jenna Gillett share findings from their research on mental defeat.  For people living with chronic pain, mental defeat can be a way of characterizing how the pain impacts a person’s perceived loss of autonomy which can lead to a loss of identity when experiencing repeated episodes of pain.  

Contributors: 

Vicky Sandy-Davis, Lead Nurse for Independent Health and Social Care, West Midlands 

Ian Taverner, Chair of the Public Advisory Group of CRIISP (Consortium to Research Individual, Interpersonal and Social Influences in Pain) 

Sarah Harrisson, Research Associate in Applied Health Research at Keele University, Specialist Pain Physiotherapist with the IMPACT Community Pain Service (Midlands Partnership NHS Foundation Trust) in Stoke-on-Trent 

Professor Nicole Tang, Director of the Warwick Sleep and Pain Laboratory, Academic Co-Lead for the Warwick Health Global Research Priority Mental Health Theme

Jenna Gillett, PhD student at Warwick University and Lecturer in Psychology at the University of Buckingham. 


Thanks

The interviews were recorded at the British Pain Society’s Annual Scientific Meeting, 2024. 


Time Stamps: 

[00:00] Introduction by Paul Evans
Overview of Pain Concern’s work and the British Pain Society’s Annual Scientific Meeting 2024 as the context for the interviews.

[00:45] Professor Nicole Tang on Mental Defeat
She explains how chronic pain impacts identity and self-perception, drawing analogies from animal behavior. Discusses mental defeat as a predictor of distress and its relationship with suicidal behavior.

[02:27] Vicky Sandy-Davis on Person-Centred Care
She explains diagnostic overshadowing and highlights the importance of personalized care for individuals with learning disabilities and chronic pain. Shares challenges in supporting offenders with learning disabilities in the criminal justice system.

[16:26] Ian Taverner and Sarah Harrisson discuss Patient Involvement in Research
They discuss the value of integrating lived experiences of chronic pain sufferers into research.
They highlight the gap in representation of individuals with severe pain in public involvement initiatives. and advocate for meaningful participation of patients in shaping research.

[19:25] Nicole Tang and Jenna Gillett discuss the Warwick Mental Defeat Study and how mental defeat impacts pain management and affects levels of suicidal behaviour.

[30:00] Nicole Tang and Jenna Gillett discuss challenges in communicating research outcomes – the importance of making tools and findings accessible to clinicians and researchers. They talk about plans to share the mental defeat questionnaire for broader use in healthcare.


Additional Resources: 

If you have any feedback about Airing Pain, you can leave us a review via our Airing Pain survey  

____________________________________________________________

Peer Support. Join the community

“Having chronic pain is very lonely.”

Join the community

Subscribe to Pain Matters

Everything you need to know about how to live with chronic pain

Subscribe

 

 

In pain? Don’t understand what’s happening?

“Having someone to help you prepare for your life through pain”

Our Pain Education Sessions

Fundraise for Pain Concern

Help us to help others

Fundraise

 

First broadcast: 04 December 2024

This edition of Airing Pain focuses on person-centred care. Person-centred care is based on the individual rather than on a generic group of patients.  

The edition is presented and produced by Paul Evans. The interviews were recorded at the British Pain Society’s Annual Scientific Meeting, 2024. 

Edition features:

Vicky Sandy-Davis, Lead Nurse for Independent Health and Social Care, West Midlands 

Ian Taverner, Chair of the Public Advisory Group of CRIISP (Consortium to Research Individual, Interpersonal and Social Influences in Pain) 

Sarah Harrisson, Research Associate in Applied Health Research at Keele University, Specialist Pain Physiotherapist with the IMPACT Community Pain Service (Midlands Partnership NHS Foundation Trust) in Stoke-on-Trent 

Professor Nicole Tang, Director of the Warwick Sleep and Pain Laboratory, Academic Co-Lead for the Warwick Health Global Research Priority Mental Health Theme

Jenna Gillett, PhD student at Warwick University and Lecturer in Psychology at the University of Buckingham. 

Transcript begins

Paul Evans: This is Airing Pain, a programme brought to you by Pain Concern, the UK charity providing information and support for those of us living with pain, our family and supporters and the health professionals who care for us. All the interviews for this edition of Airing Pain were recorded at the 2024 annual scientific meeting of the British Pain Society at Nottingham University. Each year it’s a major platform for pain management professionals, researchers, clinicians and industry leaders to come together to exchange insights and explore the latest developments in the field of pain. And we’re grateful to the British Pain Society for their support in providing facilities for us to record at these events. I’m Paul Evans.  

Nicole Tang: When an animal is being attacked, at which point they would declare defeat by showing the defeat behaviour, like head stooping down and showing, you know, signs of okay, now I’ve been defeated, stop the attack – some would just say “okay, I am giving up!” after, let’s say, ten bites. And some would not stop fighting back until, you know, they have been bitten a hundred times.  

Ian Taverner: When you’re living with pain to be asked by a researcher is quite a novel thing, but it’s so important. I think the session we had today just proved that; how important it can be and how it can change the trajectory and the direction of your research just by having people within it right from the beginning who live with pain.  

Evans: We are all different. I know, not earth-shattering news, but is it too convenient to lump individuals together under banners that suit researchers and healthcare professionals whilst ignoring the unique makeup of an individual? Here’s an example: a person living with chronic pain has a learning or intellectual disability. They’re also in the criminal justice system. That’s three boxes to tick: learning disability, prison and pain.  

How do these three interact with each other? Person-centred care – that is, a care plan or treatment based on the individual rather than on a generic group of patients – has been gaining traction for some years and in the meeting the term cropped up in several presentations. In one of them, Vicky Sandy-Davis, who is a qualified learning disability nurse, spoke about person-centred assessment of people with intellectual or learning disabilities.  

Vicky Sandy-Davis: The definition of learning disabilities has changed over the years. It used to be that we’d look at somebody’s IQ and if it was below 70 they would have. If it was between about 60 and 70 they would have a mild learning disability and then there were different stages of learning disability going down to profound learning disability, which is someone with an IQ of around 20, 10 to 20. Now, a learning disability, in terms of definition, we look at somebody’s comprehension skills, somebody’s social skills, everyday living skills… all of those things together will mean that somebody may have a learning disability and might need support. A much higher proportion have healthcare needs compared to the rest of the population. There can be behavioural issues, there can be issues with accessing healthcare and accessing generic services. Education … they might have problems getting employment for example, because I think about 7% of people with LD are in employment, and that employment might not be meaningful. So really a learning disability nurse will support a person with a learning disability in every area of their life. It’s a really holistic way to support somebody and it’s about empowering them and helping them to live independently.  

Evans: Ok, we’re speaking at the British Pain Society Annual Scientific Meeting 2024. What are you speaking to the delegates about?  

Sandy-Davis: I’ve been speaking to them about diagnostic overshadowing which is about misattributing a presentation. So, for example if somebody with a learning disability can’t communicate verbally and their behaviour changes, quite often that’s attributed to their learning disability when actually it could be that person communicating that they’re in pain. So diagnostic overshadowing is one of the things that I’ve spoken about. But also person-centred assessment, which is really important in terms of pain assessment. So, it’s about getting to know the person, working out how they communicate and how you can identify that they’re in pain.  

Evans: So diagnostic overshadowing, I mean, that means that if I have a learning disability and I do something out of character, this, that, the other, because I’m in pain, somebody might think that’s because of my learning disability and not because I’m in pain?  

Sandy-Davis: Yes. So, the scenario that I’ve used today is a person on a low-secure unit – because that’s my area of practice, really – whose behaviour changed. And it’s based very loosely on someone from my distant past, so not really identifiable at all. Somebody whose behaviour changed, and he was punching himself in the face and that resulted in him being restrained on several occasions, on his psychotropic medication being increased. So, in learning disabilities it’s been found that something like 30 to 50,000 people have been prescribed psychotropic medication with no clinical indication that they need it. And when someone’s behaviour changes for whatever reason, it’s often assumed that it’s because of their learning disability or because of an accompanying mental health problem and their psychotropic medication will be increased. So, something like antipsychotics for example will be increased. So, the problem is not tackled, the behaviour continues and they suffer the outcome. And that’s what happens with diagnostic overshadowing.  

Evans: People with chronic pain have invisible conditions.  

Sandy-Davis: Absolutely.  

Evans: How you get that understanding over can be really, really, difficult, especially when there’s a learning disability involved.  

Sandy-Davis: Exactly. If you consider for example someone with autism who also has a learning disability, they might respond to pain in a completely different way to everybody else. And trying to work out what it is that they’re responding to can be incredibly difficult, and unless you get to know that person really well you’re not going to be able to ascertain what’s causing that behaviour change. And that’s why it’s so important that we get to know the person that we’re working with, get to know the subtleties and nuances, in order to be able to ascertain how their behaviour’s changed, what their behaviour would look like in an everyday situation. I think the first question that I also ask is whether we really need that behaviour to change, is it causing anyone any problems? Is it because we don’t find it tasteful? Does it not meet our societal norms? Do we really need to change that behaviour? Is it threatening in any way? And then, is this person trying to communicate something that needs to be dealt with? 

My interest actually, over the years, has been in forensic learning disability. So, I work mainly with offenders with learning disability or intellectual disability, from the modern term. When I did work in practice as a forensic community charge nurse people would be referred to me by various means; they might have come through the police, they might have come through the courts, they might have come through families or other professional settings. The main aim of my role really was to keep them safe in the community and keep people in the community safe. And a lot of the stuff that I did was around monitoring them, making sure that legislation was being implemented correctly. Supporting them holistically as well, so if there’s any healthcare needs or anything like that, I would be there to support them. Since I worked as a community charge and a forensic community nurse I’ve actually worked in education for 13 years and then came into the Royal College of Nursing. But my interest has always been in working with offenders with learning disabilities and mental disorder.  

Evans: Why is that important to you?  

Sandy-Davis: There’s been lots of research around offenders with learning disabilities that come into contact with the criminal justice system. Prisoners with learning disability… the statistics change from around 20% of prisoners have a learning disability – and that can go up to 70% – but because learning disabilities aren’t effectively identified in the prison service, in the criminal justice system, you find that a lot of people are overlooked. So, there are a lot of people with learning disabilities that come into contact, they’re very vulnerable, they don’t get the support that they need. 

And then there’s the important aspect of miscarriages of justice. So, someone with a learning disability might not understand the process of the criminal justice system, they can be prone to suggestibility, so if they’re not interviewed in the right way, for example by the police, then they can admit to things that they don’t really understand. That can be passed all the way through the criminal justice system and then they can be incarcerated for something that they haven’t necessarily done. That’s not always the case; people with learning disabilities can be guilty of all sorts of crimes, but they’re very vulnerable in those kinds of situations.  

Evans: That’s really interesting, that the learning disability is not identified at the start of a legal process.  

Sandy-Davis: Absolutely. Yeah. It’s a big problem and it’s an ongoing problem. So, until the police receive really good effective training in identifying people with learning disabilities or get the right support from health services or learning disability specialists they’re not going to be able to identify people. And the really tragic thing in a way is that if a learning disability isn’t identified at that first point of contact with the police, that will go with them all the way through the criminal justice system.  

But one of the main ways to identify someone at the moment is from their previous record. So, if they’ve lived in residential care, for example, or they’ve received support from healthcare services that’s one of the only ways to identify someone. But of course, not everyone with a learning disability has lived in those environments or has that kind of support. So yeah, there’s some incredibly vulnerable people in the criminal justice system.  

Evans: But you’re not working within the legal system, you’re working within the healthcare system.  

Sandy-Davis: Yeah, absolutely, yeah. There are different professionals that are employed in healthcare settings that are working in partnership, I suppose, with criminal justice. So, for example there are liaison and diversion nurses that will identify people with learning disabilities and then divert them to the healthcare system. A lot of the healthcare that’s delivered in the prisons is run through private healthcare services or through the NHS. So, there are different roles for nurses in the criminal justice system and learning disability nurses especially. I mean, there have been a few pilots of learning disability nurses and mental health nurses, for example, going out on the beat with police to identify people in the community that might present with learning disability or mental ill health.  

Evans: But you’re a nurse, what’s the medical side of this?  

Sandy-Davis: Well – and that’s the big question, because a learning disability isn’t an illness, and it can’t be treated. So, learning disability nurses – although they’re trained in clinical procedures, I suppose, the same as an adult nurse and trained in dealing with healthcare problems, that’s the nursing aspect – but actually a learning disability nurse looks after all sorts of other things as well. So, some people say it’s a misnomer because we’re more of a specialist I suppose than a nurse. But we do have that clinical aspect.    

Evans: Because people are more than a health condition.  

Sandy-Davis: Exactly.  

Evans: Person-centred help is what they need.  

Sandy-Davis: Of course, yeah absolutely. And you can’t really implement a person-centred approach without getting to know the whole person and that’s what learning disability nurses are really good at, I think.  

Evans: We’ve just been through two years of COVID.  

Sandy-Davis: Yeah.  

Evans: I mean, how has that affected your area of work?  

Sandy-Davis: People with learning disabilities during COVID were at a huge disadvantage for lots of different reasons. The mortality rate was twelve times higher in people with learning disabilities. There was some really questionable practice: for example, care homes were given blanket DNR orders. So whole care homes full of people with learning disabilities were told that they didn’t need to resuscitate them because they had a learning disability. And it doesn’t get much more unfair than that. That was a big problem in COVID. I worked with people who weren’t given the right treatments. For example, a lady who was put at the bottom of the list for a respirator, even though she had respiratory problems because of COVID, who later died – passed away – because of COVID. She wasn’t given the right treatments. 

So COVID really brought out the inequalities in the way that people with learning disabilities are treated in our healthcare system. And there are other examples, things like the Francis report that resulted in deaths of people – avoidable deaths of people – with learning disabilities. The list goes on and on. And until people start to really recognize the value that someone with a learning disability has and the fact that they can contribute as much to the community as the next person, that’s always going to be the case.  

Evans: Disability is not an inability to do something. It’s society’s inability to allow that person to function.  

Sandy-Davis: Absolutely. And that sums up the role of a learning disability nurse to overcome that problem.  

Evans: That was learning disability nurse Vicky Sandy-Davis. While still focusing on the individual rather than on a generic group, in this case, all people with chronic pain, are the first hand, the lived experiences of those of us living with chronic pain adequately represented by researchers and healthcare professionals. “Beyond tokenism: Working with patients and public contributors in pain research” was another seminar at the British Pain Society Annual Scientific Meeting. Two of those presenting the session were Ian Taverner, who has chronic pain and chairs the public advisory group of CRIISP. That’s the Consortium to Research Individual Interpersonal and Social Influences in Pain. And Sarah Harrisson, who’s a clinical academic at Keele University and a physiotherapist in the community pain service in North Staffordshire.  

Sarah Harrisson: People who I know through my clinical experience, the people living with chronic high impact pain, find it really hard to engage in the things that matter. Their pain causes a lot of distress. They have a lot of disability. Asking them to take part in public involvement work or other research related activities is almost impossible. But actually, it’s really important because they are underrepresented in public involvement and in research. So, actually, the research that we do have doesn’t represent them. It represents people with less pain and less disability. So, what we need to do is we need to involve those people at that time when they have severe pain and disability and find different ways of doing that, that’s acceptable, that’s meaningful, that’s relevant to them. And I think by doing that what we hope is actually the future research will also be relevant and acceptable to this group who have really severe pain. 

Evans: I was involved with research in Warwick University and as a professional, as I’m doing now talking to you and making these podcasts for Airing Pain, I also took part as a subject. It’s a completely different feeling! I find it really good, being able to talk about things that actually I haven’t said to other people beyond my family.  

Harrisson: Yeah, and I think that’s what we’ve found just from today but also in some of the work that we’ve been doing. But actually involving yourselves in public involvement in research, helps people develop the way they self-manage their own pain conditions because they learn from other people, that actually there is no “best clinician” or there is no “new way” or “magic pill”. That helps them on that journey of living with pain, which is really difficult isn’t it?  

Evans: Ian, have you been involved as a subject in research?  

Taverner: No, I haven’t. So being involved in CRIISP was the first time I’ve done anything like this before. But it came about because when my life changed with what happened with my illnesses, I ended up at the Pain Centre in Bath, on a four-week programme there and then one of the people there contacted me and said, “CRIISP are looking for someone to be in the public advice, I think you’d be good for it.” So, I applied, thinking I don’t know where this will go, but  then I got the job, and then it really sparked this whole public involvement work for me. And with my other role that I do with helping people around cooking, they do cross a lot, because the more you listen to people and share and understand the different types of pain that people live with and how it… because I know how  it works with me, but I don’t know how it works with other people. So, once you start to get that it broadens your knowledge so much and therefore seeing how that goes into research –it’s obvious but not obvious, if that makes sense? 

Evans: What always surprises me coming to these things, is actually I hear so much common sense spoken by you lot and everybody else. Are you talking to the converted?  

[Harrisson and Taverner laugh] 

Harrisson: It makes sense doesn’t it, we do this for patients it makes sense to involve them in the research. But… it’s not widespread through research, but it is becoming more important. And we really wanted it to be visible at the conference, which is why we organised this workshop.  

Taverner: A lot of people will say, yes, we do use public contributors, but how they’re being used is really variable. So, what we were talking about today was very much about really investing in them and putting people at the centre of this rather than the periphery.  

Evans: Absolutely. It’s one thing to take part in a research programme, but not to be used as a statistic. Keep feeding back to us what the research has done, what the results are, how you’ve helped. I think that’s ever so important.  

Taverner: It’s not good enough to say, “this is what we’ve done.” It’s right, isn’t it? The people who are living with pain should be involved in the process to get to that point, not at the end of it, and that’s the big shift that it’s hard to make.  

Evans: Ian Taverner. Well, the research programme for which I was a subject is the University of Warwick Study of Mental Defeat in Chronic Pain. You can hear all about that in Airing Pain Edition 134, available from the Pain Concern website, which is painconcern.org.uk. The study’s now at the point where the data collected, including mine, is being analysed. I caught up with the study’s lead, Nicole Tang, who’s director of the Warwick Sleep and Pain Laboratory, and Jenna Gillett, who’s a PhD student at Warwick and lecturer at the University of Buckingham. Let’s just remind ourselves of what mental defeat is. Nicole Tang.  

Nicole Tang: Mental defeat is a cognitive construct that we are trying to apply to understand the psychological experience of so many patients with chronic pain sometimes have. Essentially, it’s a concept that helps us to see and feel, to understand the impacts of the daily assault of chronic pain on a person’s sense of self and identity. So, I have spoken to many, many patients with experience, how they struggle with getting on with their life.  Sometimes they feel like the pain has really taken over, that the pain has taken away the identity of who they are. They can’t do the things that they used to be able to do. They can’t do things right in front of them. And at that point when they’re struggling with pain, they can’t really see through pain into the future. 

So, I think it is a concept that helps us to understand how a person interprets their own situation in relation to the pain. And it just sort of gives us a window to understand that psychological experience. It is a concept that has been studied in other areas of psychopathology, including depression, post-traumatic stress disorder, and psychosis, and particularly in the area of suicide. So, there are lots of major theories of suicidal thoughts and behaviours that have used the concept of mental defeat to try to understand how our thoughts and interpretation of a situation, and how yourself relates to the wider context, could help us predict suicide risk. And so that is the concept that we’re trying to employ to understand particularly those people who are feeling a high level of distress when they are struggling with chronic pain.  

Evans: Well defeat signifies that it’s a battle lost. Having chronic pain is a grind, I know that. I’ve never really thought of it as a battle, something to fight against. It’s more accepting that it’s there and it will be there. But at what point does that daily grind, yearly grind, the battle, if you like, turn into defeat?  

Tang: Yeah, that’s a great question. I mean it is a highly personal question, I would say, because from the animal research where they use social defeat as a model to understand, you know, when an animal is being attacked, at which point they would declare defeat by showing the defeat behaviour – like head stooping down and showing signs of, “okay, now I’ve been defeated, stop the attack” by the attacking animal. So, it highly depends on the animal [laughs]. Some would just say, “okay, I am giving up” after, let’s say, 10 bites, and some would not stop fighting back until they have been bitten a hundred times. So, it depends. And I think a lot of different factors would determine how a person would feel at any single point. But for people with chronic pain, the daily grind really takes a toll on them, and they are particularly vulnerable to be, you know, feeling defeated by the pain when they can’t do the things that they want to do, when they can’t become the person they want to be in the first place.  

Evans: That’s a particularly graphic image, especially for those of us who watch the natural history programmes. When you see the point when the chased animal, the meal, if you like, gives up, rolls over, and that is it. And putting that into human terms, Jenna, well, I don’t know how to describe it.  

Jenna Gillett: [laughs] It’s quite difficult to describe, so you’re not the only one. Yeah, we use the animal models of social defeat because obviously it is a very difficult thing to look at in people. And as Nicole said, there are so many different factors that would influence… if you have two people with the exact same chronic pain condition, they’re still going to experience that condition very, very differently. And there’s so many different psychological factors, biological factors, and social elements as well, that are all going to play into how one experiences their pain. Even within the same person, it will maybe be different across when you first – if you get a diagnosis – when you first experience that, compared to, maybe, two, five, ten, twenty, fifty years later. You know, there’s always going to be this level of fluctuation and change. So, it is genuinely a very difficult thing to pinpoint and say, “this is exactly what mental defeat looks like in everybody”. 

The important thing is to sort of look at the big picture of mental defeat. Whether you are a clinician and you’re, you know, you’re seeing patients all the time, whether you’re someone living with chronic pain – a lot of people can relate to the experience, but people don’t necessarily put together that that’s mental defeat. So, it can look quite different in everybody. But one of the key elements to it is this powerlessness of it. So, it’s about an attack on who you feel you are as a person because of the pain. So, your sense of self might be intertwined with, you know, your experiences of chronic pain and that – as you say – that daily grind, that yearly grind, the persistent-ness of it, that takes a toll on a lot of people.  

Evans: So, I guess from one extreme, we could be just, “I’ve had enough, I’m giving up work. The things that keep me ticking over mentally, that’s my lot”. It could well be giving up and saying, “I’m going to sit at home and stare at four walls.” And at the extreme, it could be suicidal thoughts.  

Tang: Yeah. That’s why we’re trying to use the presence of defeat, mental defeat, to help us to understand that difference. Why some people may behave differently or just respond to chronic pain differently than the other one, who may be experiencing the same level of pain. You know, apparently similar pain intensity, similar pain situation, why one person will respond with a higher level of distress and disability and then the other person may be, “okay, yeah, I’ll just get on by.” But by understanding that difference, we can perhaps try and do something. Because, I mean, by saying that you feel defeated, there’s nothing to be ashamed of. Because it’s highly understandable, given that situation – if suddenly, you know, I have a lot of pain and that just won’t go away, I will think the worst, I will be very worried and I will feel like, “oh, I’m incapacitated”. So, this is highly understandable, it’s nothing to be ashamed of. 

But I think the important thing is to understand that that feeling of defeat can be changed. And so, we are looking into how to do intervention that could help people to get themselves from that deep hole that they feel there’s nothing that they can do about the pain. There’s nothing that they can do to improve the quality of life. So, we want to be able to help people change that. 

Gillett: So, some of the work that we presented at this conference was looking at the risk factors for that one end of the spectrum where, you know, the people who we can identify that they have got particularly high, maybe, levels of mental defeat and then we’re looking also at their levels of suicidal behaviour as well. So obviously this is a very at-risk group of people. So, one of the things we were looking at in the mental defeat study was those predictors of, okay, so what’s going to be these markers, these risk factors for this group of people? And some of the risk factors that we found, for example, were around obviously like the depression levels as well… You know, I mean, it sounds, okay, yes, that’s logical, that would make sense. But prior to this, there’s not been much research looking specifically at, you know, the mental defeat in the chronic pain context and tracking that across time. And then also there were some other risk factors as well. So, we looked at things initially over six months and then we repeated things again over twelve months to again see: are things staying the same? Are they slightly fluctuating? And yeah, we found that consistently with the risk factors for suicidal behaviour, it’s your mental defeat scores that are coming out as relevant, and also those depression levels as well that we looked at across twelve months.  

Evans: So, the research experiment that I took part in, suddenly living with chronic pain, was to try and work out what my attitudes were to pressure and pain? 

Gillett: A lot of the time people do research by, you know, just doing survey, cross sectional. “What happened in one single time point?” We have also done that to try to understand the relationship at the superficial level. When you joined us as a participant, that was the time when we were doing experiment to see if we can activate the sense of mental defeat, and would that have a direct and immediate effect on people’s pain responses? So, we’ve done some pain testing, get you to put your hands in a bucket of cold water to see your cold pain threshold, et cetera, et cetera, and also conditional pain modulation. So that was a fun experiment, but it’s really, really hard to carry out those experiments. So, we’ve done that and we are still looking at the data, but we have collected more data by asking people to give us some in-the-moment rating of the sense of defeat, the mood, the functioning when they’re at home, doing their own thing. So, we want to have that very realistic sense. What happened? You know, if you’re feeling defeated a little bit, what will happen to your physical activity during the day, your use of medication, whether or not you’re engaging in social activity and seeing friends, doing things that you want to do, et cetera, et cetera. 

So, we’re analysing those data in a more dynamic, temporal sense. And what we’re seeing right now at the very preliminary [laughs] analysis level is that the way how mental defeat works may be a little bit more indirect than direct.  It will affect your mood, the way how you pay attention to things, but there seems to be a rather stable association with the level of functioning during the day in different contexts. So, we are quietly excited about that, but we can only say some more once we have completed the analysis and reported that. But I think it is operating in a way that would translate from, you know, just the thought of defeat to our actual behaviour.  

And so that is largely aligned with the generic cognitive behavioural therapy model, the way how we interpret our situation, our psychological state could have an influence on our emotions, the way we feel, and also our behaviour, the way we respond to a situation.  

Evans: To me, it would be fairly obvious that the results you would get from coming to the lab and being at home, day-to-day life would be completely different. I mean, after doing the stuff in the lab… [Jenna and Evans laugh] Firstly, I was very nervous. Secondly, you come away thinking, “did I give the correct answers?”  

Gillett: Yeah, there are no correct answers.  

Evans: “What did I say? Did I mean that?” 

Gillett: [laughs] Yeah, there are definitely no right or wrong answers with these things. And that’s why it took so long for us to do because we wanted to make sure we’re capturing all these different ways of looking at mental defeat. So, in an artificial lab, highly controlled experimental setting, which was what you did when you came and joined us, that’s one way of looking at it, where you can really pin down, OK, like you say, “can we activate this sense of mental defeat?” Because if, in theory, if we can activate it, then maybe down the line, we can look at how we deactivate it. And that would, you know, obviously help people that are going to experience defeat.  

Tang: You are absolutely right. You know, there are trade-offs in an experimental setting.  

Gillett: Yeah.  

Tang: Although we have very good control of the confounding variables, but we also perhaps, you know, make you feel a little bit anxious and you are reacting to the situation as well. So, we understand that. But I have to say, Paul, you have done really well. [laughs] And I hope that our safety procedure… And I just want to have a shout out to all the participants who have come from further afield to come into the lab and really show an interest to what we are doing and help us out with doing the research. We are very appreciative of the time and effort.  

Evans: It was an amazing experience. I’m a participant in lots more research projects, mostly online now, since doing that. Because it’s such a worthwhile thing to do! 

[Tang and Gillett laugh] 

Evans: Honestly, there’s going to be no progress in anything if people don’t take part in research programmes. So, I did find that very good. And I was really well looked after. And I would do it again a hundred times over.  

Tang: Aww, thank you Paul! 

Gillett: Thank you! 

Evans: And I would encourage anybody to get involved with these things. Somebody has to do these things for science to move on. 

Gillett and Tang: Mm, yeah. 

Evans: As in any research project, there’s no point in doing it and then locking your findings in the bottom drawer. How do you put this across to – not just to people with pain – but the people who manage the pain, the physicians, the psychologists, the psychiatrists, the physios? How do you get that knowledge out there?  

Tang: So, one common point that has come up from our discussion during the symposium is that we need to have a tool to help us assess and identify those patients with high level of mental defeat with suicide risk. And so we would like to make that questionnaire freely available so that more clinicians, if they’re interested in the concept, they can just register and download the questionnaire. We will have information about the psychometric properties of the questionnaire freely available as references. So hopefully that will be a useful resource for the whole community.  

Evans: That’s Professor Nicole Tang. Just put the words Warwick Sleep and Pain Laboratory into your search engine to find out more about the Warwick Study of Mental Defeat in chronic pain. Now, if we’ve whetted your appetite for taking part in the study, those at the Warwick Sleep Lab are currently, that’s in late 2024, recruiting volunteers to take part in the study into the relationship between pain and sleep and to investigate the feasibility of new approaches with a modified version of CBT. Go to the same website or email: sleeppainstudy@warwick.ac.uk for more details.  

And I’ll remind you, as I do in every edition of Airing Pain, that whilst we in Pain Concern, believe the information and opinions on Airing Pain are accurate and sound, based on the best judgments available, you should always consult your health professionals on any matter relating to your health and well-being. They’re the only people who know you and your circumstances and therefore the appropriate action to take on your behalf.  

Now, it’s important for us at Pain Concern to have your feedback on these podcasts, so that we know that what we’re doing is relevant and useful and to know what we’re doing well and maybe not so well. So do please leave your comments or ratings on whichever platform you’re listening to this on or the Pain Concern website, of course, which is: painconcern.org.uk. That’ll help us develop and plan future editions of Airing Pain. But to end this edition of Airing Pain, I leave you with Vicky Sandy-Davis on the importance of recognising the value of person-centred care.  

Sandy-Davis: There is a much wider picture than somebody’s behaviour. And people who don’t communicate verbally, for example, will communicate through their behaviours quite often. And it’s easy to react to those behaviours rather than proactively work with those behaviours. We tend to look at a person who behaves in a way that we don’t find acceptable, doesn’t meet our social norms. We try and change that behaviour instead of thinking about the reasons for that behaviour and changing the environment around the person. And that’s the basis for positive behaviour support. So, we need to make sure that we’re properly assessing a person’s behaviour in a person-centred way to work out what the causes of that behaviour are and to see what we can change to enable that person to live as a valued member of a community. 

Transcript ends

Transcribed by Owen Elias

© 2010-2024 Pain Concern. All Rights Reserved. 

Registered Charity no. SC023559.  

Company limited by guarantee no. SC546994.  

62-66 Newcraighall Road, Edinburgh EH15 3HS. 

Peer Support. Join the community

“Having chronic pain is very lonely.”

Join the community

Subscribe to Pain Matters

Everything you need to know about how to live with chronic pain

Subscribe

 

 

In pain? Don’t understand what’s happening?

“Having someone to help you prepare for your life through pain”

Our Pain Education Sessions

Fundraise for Pain Concern

Help us to help others

Fundraise

 

We’re excited to share the launch of the Chronic Pain Knowledge Hub, a new resource from NHS Education for Scotland. This hub has been developed in partnership with the National Pain Education Group, of which Pain Concern is a member.

What is the Hub?

The Hub was created as part of the Scottish Government’s Pain Management service delivery. It offers a wealth of resources, including the Interactive Chronic Pain Toolkit and a series of training modules. This ‘one-stop shop’ equips all NHS and Partnership staff with practical tools to develop their knowledge and skills in chronic pain management.

Chronic Pain Knowledge Hub

Why do we need the Hub?

Chronic pain affects 38% of adults in Scotland. Also, it often coexists with other long-term health conditions, impacting many aspects of daily life and overall health. Consequently, most frontline NHS and partnership staff will encounter individuals affected by chronic pain in their day-to-day work. Unquestionably, the Hub, including the new modules, provides a valuable resource for colleagues across health and social care and the third sector.

Visit the Hub

Visit the Hub to sign up and explore these valuable modules and enhance your understanding of chronic pain.

Lou (Helpline Team member and Dr Nicola Rhind (National Lead Clinician for Chronic Pain). Lou, with lived experience, provided key patient insights to shape these modules.
Lou (Helpline Team member) and Dr Nicola Rhind (National Lead Clinician for Chronic Pain). Lou, with lived experience, provided key patient insights to shape these modules.

Other Resources

The Pain Toolkit is for people who live with persistent pain and healthcare teams who support them. 

Peer Support. Join the community

“Having chronic pain is very lonely.”

Join the community

Subscribe to Pain Matters

Everything you need to know about how to live with chronic pain

Subscribe

 

 

In pain? Don’t understand what’s happening?

“Having someone to help you prepare for your life through pain”

Our Pain Education Sessions

Fundraise for Pain Concern

Help us to help others

Fundraise

 

After the amazing response to our last free, online mindfulness taster sessions, we are thrilled to be bringing them back!

The design of these sessions is to give you a peek into the potential benefits of mindfulness for chronic pain, sample a few practices, and answer all your questions. They will run in advance of our full 8-week course starting in January 2025.

Why Mindfulness?

Mindfulness is able to help people manage chronic pain by:

  • improving focus
  • reducing stress
  • fostering emotional balance

Beyond anecdotal evidence, research shows that mindfulness can positively impact pain management by improving quality of life.

You can choose from 2 different sessions:

Meet your guide: Cath Ashby

Cath Ashby – Mindfulness Trainer

In collaboration with The Everyone Project, we’re delighted to have Cath Ashby, an experienced mindfulness expert, lead these sessions. Cath has been teaching mindfulness since 2020, after personally benefiting from mindfulness during an NHS Pain Clinic’s 8-week course. As someone living with chronic pain herself, Cath understands the transformative power of mindfulness, and it has since become a central part of her life.

Resources:

What previous course participants said:

‘I have learned to just enjoy the moment, not dwell on the past or worry too much about the future.’ 

~ Previous Course Participant

‘I think it has had a very positive impact on my day-to-day life. As well as more formal practice, I find myself just taking a moment when I feel overwhelmed which makes a mental and physical difference.’ 

~ Previous Course Participant

‘From the very first session I learned how to settle my mind as well as my body which is beneficial in all areas of my life…’ 

~ Previous Course Participant

Peer Support. Join the community

“Having chronic pain is very lonely.”

Join the community

Subscribe to Pain Matters

Everything you need to know about how to live with chronic pain

Subscribe

 

 

In pain? Don’t understand what’s happening?

“Having someone to help you prepare for your life through pain”

Our Pain Education Sessions

Fundraise for Pain Concern

Help us to help others

Fundraise

 

We are delighted to announce that we have been awarded funding by the People’s Postcode Lottery. This will go towards our core costs which helps us with our activities to support people living with chronic pain.

Peer Support. Join the community

“Having chronic pain is very lonely.”

Join the community

Subscribe to Pain Matters

Everything you need to know about how to live with chronic pain

Subscribe

 

 

In pain? Don’t understand what’s happening?

“Having someone to help you prepare for your life through pain”

Our Pain Education Sessions

Fundraise for Pain Concern

Help us to help others

Fundraise

 

First broadcast: 09 October 2024

This edition of Airing Pain focuses on two conditions affecting the gut: Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD).

The edition is presented and produced by Paul Evans. The interviews were recorded at the British Pain Society’s Annual Scientific Meeting, 2024. 

Edition features:

Dr David Bulmer, Associate Professor at Cambridge University, specialising in visceral pain and gastrointestinal disease, with a special interest in IBS, IBD, and pain.  

Professor Rona Moss-Morris, Professor of Psychology as Applied to Medicine and Head of the Department of Psychology at the Institute of Psychology, Psychiatry and Neuroscience, King’s College London. Lead for Digital Therapies at the NIHR Maudsley Biomedical Research Centre.  She has a special interest in factors that affect symptom experience and adjusting to chronic medical conditions. 

Transcript begins

Paul Evans: This is Airing Pain, a programme brought to you by Pain Concern, the UK charity providing information and support for those of us living with pain, our family and supporters and the health professionals who care for us. I’m Paul Evans. 

Rona Moss-Morris: If you have a condition like Inflammatory Bowel Disease, people assume that the pain is just related to the inflammation and the disease. And we have quite a lot of work now to show that at least around 40% of people continue to experience symptoms when the disease has remitted and there is no evidence of inflammation.   

David Bulmer: People have done lots of genetic work and identified a number of genetic mutations that are common in IBD patients. Whereas, in IBS the very latest research suggests that actually it’s a localised allergy specific to the gut. 

Moss-Morris: “Your disease is actually well controlled at the moment and so you don’t need to worry about the symptoms.”  Now if you’ve got very debilitating, distressing and uncomfortable symptoms that are stopping you doing things, you worry.   

Evans: Irritable Bowel Syndrome and Inflammatory Bowel Disorder – IBS and IBD – are two conditions affecting the gut. IBS is the most common disorder of the digestive system and IBD is a term used for a group of digestive conditions, the most common of which are Crohn’s Disease and Ulcerative Colitis. Each condition comes with its own set of issues, but common to both is pain.   

So, what separates these outwardly similar sounding conditions? David Bulmer is Associate Professor of the Department of Pharmacology at the University of Cambridge. He’s a research scientist in the field of visceral pain – that’s pain from the gut – and for the past two decades he’s been researching the causes of pain in conditions like IBS and IBD.   

Bulmer: They sound very similar but they’re not the same thing. So Inflammatory Bowel Disease is an autoimmune condition, like arthritis, and the gut becomes very inflamed. So, in IBD it’s a bit more obvious what’s causing the pain.   

People may be more familiar with IBS – Irritable Bowel Syndrome – and the difference with IBS is that there’s no clear change, other than the pain, in the appearance of the bowel so the patients undergo, you know, lots of investigations to confirm that they have no disease – yet, obviously, they have pain.   

Evans: What are the differences in how the patient experiences these conditions?  

Bulmer: The actual experience may be quite similar. And certainly my dad was diagnosed with Inflammatory Bowel Disease quite recently but was told, you know, for a long time that he probably just had IBS. Because both conditions present with pain but also with disordered gut motility – and that just basically means you become constipated or, you know, you have diarrhoea and go to the toilet a lot. The key difference is in the underlying cause.  In IBD it’s thought to be an autoimmune condition and the immune cells attack the gut. Whereas in IBS it looks to be more like a localised allergy – and that only occurs when it’s sort of challenged. That creates a lot of problems for the patients; so if they go to the doctor and that isn’t currently happening there’s nothing really to see. But the next day, you know, there may well be an attack or a response. So if you are not looking at the right time you see nothing.   

So, an analogy I always quite liked was: if you can imagine if you stand on a bridge over a motorway and look down then the chances are there wouldn’t be a car and you might conclude there’s no cars on the motorway. But if you look down the motorway you’ll see there is, in fact, lots of cars on the motorway and I think IBS is a bit like that.  

Evans: You said that IBS may be an allergy issue but IBD is an autoimmune issue.  

Bulmer: Yes. Yes. 

Evans: What’s the difference?  

Bulmer: So, in IBD, you know, it tends to be a familial condition. People have done lots of genetic work and identified a number of genetic mutations that are common in IBD patients. Whereas in IBS the very latest research suggests that actually it’s a localised allergy, specific to the gut.   

So, there was a fantastic study from a group in Leuven last year, a clinician called Guy Boeckxstaens. And what Guy’s group was able to show is that, if they put a food allergen on the tip of an endoscope that they inserted into the gut, they could trigger a localised allergic response. But the patients had no response to that trigger if you applied it to the skin in a conventional allergy test.  

So, they don’t have a food allergy, per se, and that would be tested in the skin. But actually, within the gut, there’s a localised allergic response that we were just missing, really. I suppose it’s a bit like comparing hayfever, you know, with something like psoriasis. They’re both things that are triggered by the immune system but there’s different immune cells involved. The cells involved in psoriasis tend to be more destructive or aggressive whereas with hayfever, you know, you get a runny nose.   

Evans: So, I guess, if it’s a localised allergy in the gut… 

Bulmer: Yup. 

Evans: …finding out what that allergy is – problem solved?  

Bulmer: Yes, for that group of patients. Certainly, for a lot of these conditions which affect a lot of people there’s a danger we lump together people based on their symptoms and assume it’s the same thing. So certainly for a sub-group of patients that is going to be super important and it probably will be, as you say, be ‘problem solved’. And certainly there’s data out there on, you know, antihistamines showing efficacy in patients and drugs that stabilise an immune cell called the ‘mast’ cell, which is thought to be at the heart of allergic responses. So, to some degree, that’s true.   

Evans: Tell me if I’m wrong here – some antidepressants are used for people with IBS? 

Bulmer: The data there is mixed but there was a very good study done recently by a group in Leeds that showed that a specific antidepressant called amitriptyline is effective in a sub-group of IBS patients. Now the interesting thing about amitriptyline is it’s an old drug and it has effects against multiple targets in the body, one of which is the histamine receptor. So, you know, certainly one of the questions I would ask is whether amitriptyline is working as an antihistamine rather than as an antidepressant. And, in that study, the dose of amitriptyline is low and lower than what seems to be its effect as an antidepressant. I’m of the opinion that some of that efficacy is coming from its antihistamine actions for sure.   

Evans: So, that’s IBS – Irritable Bowel Syndrome. IBD – how is that treated?  

Bulmer: An area of great success actually, over the last 20 years, so typically that will be treated with immunosuppressives so it’s, you know, common to start patients, perhaps, on steroids as an acute treatment to bring the inflammation under control. More recently we’ve had this explosion in the biological treatments for autoimmune conditions and the anti TNFs, I think, were first shown to work. So, it’s a drug that targets the molecules that signal between immune cells, called cytokines, and they’ve been a genuine revolution in the treatment of IBD. So there’s now a very wide palette of effective anti-cytokine treatments.   

So, in terms of, you know, controlling the inflammation in Inflammatory Bowel Disease there’s been great progress. And I think, increasingly, that the sort of call from the patients is that the pain is not necessarily being treated as well. You know, we shouldn’t see that as a failure – it’s just an indication of what we can do to improve things. And I think if we put as much attention and focus on treating that as we have with the inflammatory disease, which I think was the priority – it’s a serious condition, you know, people were going for surgery because of the inflammation in the bowel and that’s been greatly reduced – so that’s the priority. But I think if we were to put the same focus on treating pain then we would crack that nut as well.   

So, we’re very interested in what causes pain during the active inflammation and we think the same cytokines are important. Some of them are important in pain and inflammation but we think some of them are more important in pain than inflammation. So, they might be the ones we’re not targeting at the moment which is why some of the patients are experiencing pain despite an improvement in their underlying condition.   

What’s particularly challenging, I think, in IBD is how do you treat pain when the patient is then in remission from the sort of primary inflammatory disease and, again, there’s a lot of patient advocacy to deal with those conditions. And that’s a very much understudied area. So there’s a feeling that it’s similar to IBS but there’s no reason for it to be similar to IBS, if that makes sense. The only sort of similarity is that the bowel now looks normal but the patient is still in pain. You know, whether it’s the same condition or not, I think, is something that needs to be considered. So, I think there’s a temptation to see it as something that can be treated with the treatments for IBS and, therefore, we don’t need to do any work on it – but that’s not true.   

Evans: It’s something that’s occurred, well several times, from people I’ve been speaking to at this British Pain Society Conference. There can be a failure of professionals in that, yes, we’ve cured the condition but the patient is still in pain. Job done, but… 

Bulmer: Yes, it feels intuitively incomplete doesn’t it? You know, it’s kind of if you got the car back from the garage and, you know, we’d fixed the problem with the tyres but the windscreen wipers still weren’t working, you would want them to fix the windscreen wipers as well [laughs].   

So I can understand from a clinical perspective that the initial goal is to treat the more – and you have to be careful with the word ‘serious’ because pain is a serious problem but, you know – the thing that’s going to cause the greatest damage to your body, that might be irreversible, first.   

Evans: So, thinking of the patient experience, somebody experiencing the symptoms one of these two conditions, starting out on their pain journey in primary care with their GP – what should they be asking their practitioner? And, in fact, what should the GP be asking them, to differentiate between the two?   

Bulmer: I think the clinicians are very, very switched on to these issues and they are very aware of the literature. I mean my advice would be to engage in that dialogue with the clinician – I mean certainly in IBD at the moment the latest treatments at the clinical trials are including pain as a secondary end point because clinicians, scientists and companies alike recognise the importance of meeting that milestone. 

In terms of IBS there is an appreciation, as you mentioned, of drugs like amitriptyline more widely now that they can provide some efficacy for some patients, there’s a growing appreciation of, perhaps, the role of the antihistamines, but also the dietary interventions with the low FODMAP diet which is a restriction diet. And it’s not a diet you can go on for a long period of time. There’s a temptation to see it as excluding foods that you may have an adverse reaction to but, what’s happening when you exclude these foods, is it’s depriving the so called ‘bad bacteria’ in the gut of a fuel source and you only go on the diet for a relatively short period of time. But it allows those levels to reduce, the good bacteria to sort of grow and dominate again and it resets your microbiome and that coincides with a reduction in symptoms. 

Evans: The microbiome is very… “fashionable” is the wrong word, but people do need to talk to their doctors before trying any of these things.   

Bulmer: You know, a low FODMAP diet is not something you that should be taking over a long period of time. There’s lots of very important nutrients and vitamins that you’ll get from those types of food. that’s why I’m hesitant to use the word “diet”, really – it’s an intervention, I think.  But, nevertheless, it sort of points to the microbiome as a causative factor which intuitively makes a lot of sense in the gut. It doesn’t seem like rocket science that these trillions of bacteria in the bowel may be contributing to events. You know how you then get out of that, whether it’s through a regulation of the food you eat or through other more targeted mechanisms is something that’s only going to grow, as a field, in the future.   

Evans: David Bulmer of the University of Cambridge.   

Of course, not just for the FODMAP diet, I’ll remind you as I always do in every edition of Airing Pain, that whilst we in Pain Concern believe the information and opinions on Airing Pain are accurate and sound, based on the best judgments available – you should always consult your health professionals on any matter relating to your health and well-being. They’re the only people who know you and your circumstances, and therefore the appropriate action to take on your behalf. 

OK, let’s go back to that term ‘remission’ particularly as it’s applied to IBS or IBD.   

Rona Moss-Morris is Professor of Psychology at King’s College London.   

Moss-Morris: Even though the disease management has improved dramatically when you would be considered, perhaps biomedically, to be in remission – in other words there’s no evidence of inflammation and so forth – there’s a good, at least around 30 to 40% of people, who continue to experience – maybe not as extremely – but they will still experience a level of uncomfortable symptoms including pain, fatigue and urgency are the main three they experience.   

Evans: I don’t understand how a disease can be considered ‘in remission’ if the patient is still experiencing discomfort or pain? 

Moss-Morris : Yes, I think that’s a really good point. So, at the moment remission is, I guess, defined as “symptom free”. So, you’re quite right, then you would continue to say that, no, these people are not in remission. But because that’s then also assumed that your inflammation has gone, what it doesn’t explain is that what happens when the inflammation from all the biomarkers appears to be wellcontrolled but you are still experiencing symptoms. And it’s those people who often might be told, “well actually you don’t need to worry because your disease is actually well controlled at the moment and so you don’t need to worry about the symptoms.” 

Now if you’ve got very debilitating, distressing and uncomfortable symptoms that are stopping you doing things – you worry.  Anybody would do that.  So, because there isn’t anything routinely offered to those patients in terms of treatment that’s not a biomedical treatment, I think sometimes it’s easier just to say “you have irritable bowel-like symptoms” – is often what patients get told, you know – so, “at least you know your disease is well controlled so you don’t have to worry so much about that.” 

So, I think it’s kind of a twofold thing. One is that there is the expectation that if you have a disease then it’s all driven by the disease and that there are not other factors which help maintain symptoms. The other fact is because we don’t have routinely good treatments to offer in that situation it’s very challenging for healthcare professionals. Because healthcare professionals want to talk about things that they can do things about.    

Evans: This all makes sense to me as a patient. So, what are you, as a psychologist, telling the physicians here? 

Moss-Morris: One of the things that I’ve been talking a little bit about is a clinical trial which we have yet to publish so I can’t expand on the results too much but we developed an intervention, based more on the principles of cognitive behavioural therapy and around managing all three symptoms:  pain, fatigue and urgency. So quite often I think you often get a programme where you treat pain or you treat fatigue or you possibly treat incontinence urgency as three separate things – and actually when you’ve got the constellation of symptoms that’s not very efficient for people to do them. So we try to pull together some of the psychological factors that we know help maintain symptoms and design a programme based on that. And because of the challenges we have in the healthcare environment that we are currently working there are very few healthcare professionals. There are very few healthcare professionals trained in this particular approach too – so we designed a digital interactive programme, and we designed it in a way that that IBD nurses – so they’ve got a speciality in IBD – might be able to provide just some additional support alongside. But when we spoke to the IBD nurses they kind of said “well actually we’ve got these massive workloads already – how are you going to expect us to do this as well?” 

So, based on the interviews we did with them, the person living with IBD would start the programme on their own, do the first session and then they would just have a half an hour call check-in with the IBD nurse that we had specially trained in the programme. And then they would just get a weekly message to find out how they’re progressing, the nurses could see some of what the person was doing.  

So, we were trying to be pragmatic I guess.  You know, as a psychologist would that be the way I would most like it delivered? No, I would love to offer everybody a trained CBT therapist to deliver that – that’s just not going to be possible. So our results showed that, overall, we had a large group of people, overall it didn’t seem to work. So that was the disappointing news.  The, perhaps, more positive news was that people who had IBD, or Inflammatory Bowel Disease and they also had symptoms of Irritable Bowel Syndrome – in other words they were the people who probably had the worst symptoms, ongoing symptoms – they did seem to benefit. So we had what we call a ‘sub-group’ who seemed to benefit from the analysis. So I suspect maybe we recruited too broadly and it might only be a sub-group of people with more severe symptoms who are going to benefit from this approach.   

Evans : CBT – Cognitive Behavioural Therapy? 

Moss-Morris: That’s correct, yes.   

Evans: Just explain what that is.  

Moss-Morris: Firstly, I should say it’s not one thing.  It’s a group of therapies that use particular methods or techniques. So people often think, you know, if somebody’s getting CBT, you’re treating their mental health.  Well, that’s actually not true, it would be true if I’m using CBT for depression or CBT for anxiety and even then there’ll be very particular types of CBT. So if you have generalised anxiety disorder or you have social phobia the CBT is different.   

So, when we talk about CBT in this context it’s CBT that has been designed specifically for managing symptoms in Inflammatory Bowel Disease. And so what we do is we look at the evidence of what are the factors that seem to be associated with higher levels of pain, fatigue and urgency in IBD. And there are certain ways of thinking about the symptoms and responding to the symptoms that seem to help perpetuate them. So after you’ve had that disease flare the symptoms are not settling down and some of that seems to be things like increased anxiety about your gut, so people who are more anxious about their gut and worrying so they’re thinking about it a lot more, people who just see the symptoms in a more negative light, certain behavioural patterns and particularly something that we’ve noticed across conditions where symptoms get maintained is what we call ‘boom or bust’ or ‘all or nothing behaviour’. And this is something a lot of us identify with, that kind of sense of when you’ve been feeling ill when you have a good day you often push yourself quite hard because you think “OK, I’m feeling good, I’m going to get all the things done that I haven’t managed to do”, and then what often happens, because you’ve pushed quite hard, is that the symptoms flare again and then people say “oh look here we go, back to square one, back to bed”. 

And so that pattern actually becomes quite unhelpful over time. So, it’s addressing those factors – very specifically. And also, within that, looking also at mood because I think the more debilitating and uncomfortable your symptoms are, and if people have been dismissing it, you actually do get quite anxious and often quite down and depressed so we will also look at how to manage mood in the context of that as well.   

Evans: So, you talk about the ‘pain cycle’? 

Moss-Morris: It is a pain cycle but it’s kind of, I guess, not pain on its own it’s pain, fatigue and urgency all together. And what we do do in that programme is people can decide whether they want to focus more on one or the other so there’s general principles of all three and then people can then say, “well I’m going to focus more on my pain” or “I’m going to focus more on my fatigue” or “more on my urgency”. Because what happens is, even if you have all of them, you’ll have one that’s worrying you more quite often.   

Evans: And, in simple terms, if you are worrying about what is happening, that feeds into the business and it gets worse and worse and worse? And you have to break that cycle. Am I right?   

Moss-Morris: Yes, that’s exactly right. So, we talk a lot of about vicious cycles, how do we break them and there are various different ways you can break them. And everybody’s cycle is slightly… well, not everybody’s completely different – but everybody has an individualised cycle so it won’t look exactly the same for everybody. So when we build digital programmes like this we try and tailor them very specifically. We ask people lots of questions and then tailor the treatment according to what the issues might be for them specifically.   

Evans: How does it work in practice? Or haven’t you got that far with it yet?  

Moss-Morris: No, well we haven’t got that far yet. So, what we would hope would happen in practice is that you would have some skilled healthcare professionals in this area who would be able to support programmes like this. That if you went to your gastroenterologist, to your IBD nurse, and you were struggling with symptoms – this could be offered as, you know, “we have this app, this is how it works.” Give them a bit of an explanation of why these things work – because I think the difficulty is sometimes if you offer a more behavioural approach people think, “oh you’re not taking this seriously, you don’t realise that these are very real physical symptoms”. So I think it has to go hand in hand with a really good explanation of why very real physical symptoms are made worse by these factors. I think if we could have a pathway like that we would need the NHS to pay for these apps a bit like how they pay for drugs because, you know, they cost money to support and maintain. And then you would need a healthcare professional workforce to support them. 

But I think we can do that quite efficiently. So that’s where we would like to land up but I think there’s quite a few hoops – quite a lot of hoops – to get to – before we get there.   

Evans: I’d be surprised if there were too many barriers against doing that because apps are becoming the thing for sleep, for various conditions.   

Moss-Morris: I think this is true but we don’t have a pathway within the NHS for them. So, we have a lot of apps – not many evidence-based apps – so I think there’s a difference there. So, I think we need a national strategy to very carefully evaluate apps like we evaluate medicines. And I think that is happening; within NICE there is now a NICE HTA pathway, a NICE pathway which is evaluating what is the evidence-based apps. So we are starting to have that now.   

The other thing is regulation because it absolutely needs to be regulated.  But, actually, that’s a very costly and time-consuming process. So, it’s encouraging industry to pick these up, to go through all these processes, for people to go through the NICE processes. But even when people have gone through that, at the moment, the uptake within the NHS is not happening.  So, you’re quite right, I think there’s an appetite for them but there’s not a structure for them. There’s quite a lot of reasons for that at the moment.  So, you know, if you have a new pharmaceutical there’s a centralised process for that within NICE. You know, NICE will evaluate the drug and will say “the evidence and the cost effectiveness for this is good and the NHS is going to provide this for people”. 

At the moment there isn’t that centralisation for digital products. So, if I say “I have this product” then I might have to go to the hospital, we’re in Nottingham at the moment, go to the hospital and say to the Trust: “I have this app that I think could work. Would you be prepared to procure it and buy it for your patients? This is the cost of it. You’ll need to train your healthcare professionals to deliver it…” etc, etc.  

Now, in my experience, it’s taken us a year and a half with products to get a Trust to get to that point. Depending on the air we have about 220 Trusts so you can imagine the time and cost to set that up within the current structure. So we need some kind of centralisation of that, we need to maybe train a centralised pool of healthcare professionals who can support this across conditions – because it’s not only Inflammatory Bowel Disease, there are a lot of people with medical conditions who struggle with similar symptoms. So, there’s lots of structural barriers that I think we need to overcome.   

Evans: The downside of digitisation is that you lose the personal touch.  

Moss-Morris: Yes, that’s absolutely right and that’s why we are very adamant that we want products which are also healthcare professional supported, so that you have a combination. So you make the healthcare professional time more efficient but you’re not saying to the person, “here’s an app – off you go”. Because – you know, it’s a bit like if you are doing an exercise programme completely online versus you had a trainer that you checked in with every now and then… You know, they are different things – someone can actually correct you, you can have conversations if your problems are more complex than are being dealt with in the app, you can be escalated, you can be triaged up. So our vision with digital, I guess, is to have a stepped care approach. You might have the bottom care app which is just a simple app for somebody who is actually managing pretty well but would just like to learn some pointers. Then you have the healthcare professional supported app where you first have an initial consultation, they show you how to use the app. And that’s particularly important – we have a digital divide, you know, not everybody uses mobile phones to the same degree. We need some people who need support but then they also get regular check-ins to come and see how they are going.  

For people with a very complex problem then actually we should be offering the one-to-one with a healthcare professional. So I don’t think digital should replace people, but I think it could certainly make something much more scalable where it can be offered to more people.  

Evans: That’s Rona Moss-Morris, Professor of Psychology at King’s College, London.   

Now it’s important for us at Pain Concern to have your feedback on these podcasts so that we know that what we’re doing is relevant and useful, and to know what we’re doing well or maybe not so well. So do please leave your comments or ratings on whichever platform you’re listening to this on or the Pain Concern website of course, which is painconcern.org.uk. That will help us develop and plan future editions of Airing Pain.  

All the interviews for this edition of Airing Pain were recorded at the 2024 Annual Scientific Meeting of the British Pain Society at Nottingham University. Each year it’s a major platform for pain management professionals, researchers, clinicians and industry leaders to come together to exchange insights and explore the latest developments in the field of pain and we’re grateful to the British Pain Society for their support in providing facilities for us to record at these events.  

Now to end this edition of Airing Pain I was just wondering what message Rona Moss-Morris, as a psychologist, was telling the delegates.  

Moss-Morris: We need a move away from this very simplistic explanation of pain and other symptoms. I think we need to just routinely not have a simple message that remission equals a kind of lack of inflammation, lack of symptoms. I think we need to make it very clear that a good percentage of patients will continue to experience symptoms, less severe symptoms often, but even when they are in remission they will continue to experience them.  I’d like to see a standardised scientific explanation for that, so that we can explain to people why they have symptoms in remission. Not just to say “oh it’s nothing to worry about” because actually these are very real symptoms. So we need an explanation for it and we are still building that up, I don’t think we have all the answers to understand that, but I think we have some answers.  

And then I think we need routinely to offer treatments for those symptoms that are not based on biomedical treatments. It’s not that you stop the biomedical treatments, those are clearly needed to manage the disease but I think there are other things that we can do to help people manage symptoms better.  But it’s just not something that is ever, well mostly, offered to people.    

Transcript ends

Transcribed by FCL 

© 2010-2024 Pain Concern. All Rights Reserved. 

Registered Charity no. SC023559.  

Company limited by guarantee no. SC546994.  

62-66 Newcraighall Road, Edinburgh EH15 3HS. 

Peer Support. Join the community

“Having chronic pain is very lonely.”

Join the community

Subscribe to Pain Matters

Everything you need to know about how to live with chronic pain

Subscribe

 

 

In pain? Don’t understand what’s happening?

“Having someone to help you prepare for your life through pain”

Our Pain Education Sessions

Fundraise for Pain Concern

Help us to help others

Fundraise

 

This edition of Airing Pain focuses on two conditions affecting the gut: Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD). Both affect the digestive system, and both cause pain. 

In this episode we learn about what separates these outwardly similar sounding conditions, how they are diagnosed, and what treatments might be available. 

Dr David Bulmer discusses the key differences and distinguishing features of IBS and IBD, the latest research into these conditions, and potential medicinal treatments for managing the pain they cause.  

Professor Rona Moss-Morris sheds light on remission, pain, and symptom management for IBS and IBD, and the challenges these conditions present. We hear about research into the use of Cognitive Behavioural Therapies designed specifically to help manage IBS and IBD symptoms.


Contributors: 

Dr David Bulmer, Associate Professor at Cambridge University, specialising in visceral pain and gastrointestinal disease, with a special interest in IBS, IBD, and pain.  

Prof. Rona Moss-Morris, Professor of Psychology as Applied to Medicine and Head of the Department of Psychology at the Institute of Psychology, Psychiatry and Neuroscience, King’s College London. Lead for Digital Therapies at the NIHR Maudsley Biomedical Research Centre.  She has a special interest in factors that affect symptom experience and adjusting to chronic medical conditions. 


Thanks

The interviews were recorded at the British Pain Society’s Annual Scientific Meeting, 2024. 


Time Stamps: 

01:29 Paul Evans introduces Dr David Bulmer, Associate Professor at the Department of Pharmacology at Cambridge University. 

01:46 Dr David Bulmer explains the difference between Irritable Bowel Syndrome and Inflammatory Bowel Disease and how they are diagnosed. 

02:50 Bulmer discusses research into the potential causes of IBS and IBD, including localised allergic response and potential genetic markers. 

06:18 Bulmer describes a study into the use of antidepressants for the treatment of IBS.  

07:29 Bulmer discusses new treatments for Inflammatory Bowel Disease, and how far these impact the actual pain experienced. 

12:17 Bulmer explains the ‘Low FODMAP’ diet treatment. 

14:17 Evans introduces Professor Rona Moss-Morris, Professor of Psychology as Applied to Medicine and Head of the Department of Psychology at King’s College London. 

14:22 Moss-Morris explains the term ‘remission’ and how it is applied to IBS and IBD. 

16:33 Moss-Morris discusses clinical trials using Cognitive Behavioural Therapy (CBT) for those with IBS and IBD symptoms. 

18:53 Moss-Morris explains what CBT is and how it is used. 

23:16 Moss-Morris discusses the use of apps and digital approaches to treatment. 

27:55 Moss-Morris gives a final message on pain.  


If you have any feedback about Airing Pain, you can leave us a review via our Airing Pain survey  

____________________________________________________________

Peer Support. Join the community

“Having chronic pain is very lonely.”

Join the community

Subscribe to Pain Matters

Everything you need to know about how to live with chronic pain

Subscribe

 

 

In pain? Don’t understand what’s happening?

“Having someone to help you prepare for your life through pain”

Our Pain Education Sessions

Fundraise for Pain Concern

Help us to help others

Fundraise

 

Sam Mason from Pain Concern discusses NHS Fife’s Chronic Pain Management Initiative on BBC Scotland’s The Nine

One of August’s highlights was the appearance of our very own Sam Mason on BBC Scotland’s news program The Nine. She offered insights into NHS Fife’s Chronic Pain Management Initiative to reduce the use of strong painkillers.

NHS Fife’s Chronic Pain Management Initiative
Clip from BBC Scotland’s The Nine about NHS Fife’s Chronic Pain Initiative aired on 15 August 2024

NHS Fife’s approach focuses on educating patients about the limited effectiveness of strong painkillers and promoting alternative pain management techniques. The initiative encourages collaboration between patients and healthcare professionals, such as physiotherapists and occupational therapists, to explore non-drug interventions that can help manage pain more effectively and sustainably.

Sam Mason Discusses Pain Management Alternatives

In the second clip, Sam discusses the broader implications of NHS Fife’s initiative. She emphasises that while painkillers have a role, they are only one part of a comprehensive pain management strategy. Sam highlights the benefits of alternative therapies like mindfulness, breathing exercises, and movement activities. She also touches on the importance of community support, sharing how peer-support groups can provide invaluable emotional and social benefits to those living with chronic pain.

The Need for a Holistic Approach to Chronic Pain

This discussion on BBC Scotland underscores the need for a holistic approach to chronic pain management. NHS Fife’s initiative serves as a model for reducing dependency on strong painkillers and encouraging the use of alternative therapies that can lead to more sustainable and effective pain management. By educating and empowering patients, initiatives like this can significantly improve the lives of those living with chronic pain.

Resources

Pain Concern provides many free, high-quality resources to educate and empower individuals with chronic pain.

Explore over 130 Airing Pain Podcasts to help you learn more about managing chronic pain:

Find out about our Pain Education Sessions

Explore how the Pain Navigator Tool can improve communication with health professionals

Peer Support. Join the community

“Having chronic pain is very lonely.”

Join the community

Subscribe to Pain Matters

Everything you need to know about how to live with chronic pain

Subscribe

 

 

In pain? Don’t understand what’s happening?

“Having someone to help you prepare for your life through pain”

Our Pain Education Sessions

Fundraise for Pain Concern

Help us to help others

Fundraise

 

Headshot of Professor Andrew Rice who is appointed the new President of the International Association for the Study of Pain

Professor Andrew Rice Appointed President of IASP

Courtesy of Imperial College London

We are thrilled to announce the appointment of Professor Andrew Rice as the new President of IASP (International Association for the Study of Pain).

Renowned World Expert

A renowned world expert in neuropathic pain, Professor Rice brings a wealth of experience and knowledge to this important role. Based at Imperial College London, he becomes the first English based President in IASP’s 50-year history.

Professor Rice’s work is widely recognized and funded by notable organisations, including the European Commission and the Wellcome Trust.

President-Elect

His election to the IASP presidency follows a two-year term as President-Elect. During this period he played a significant role in shaping the association’s priorities and initiatives.

2025 Global Year Theme

At the 2024 World Congress on Pain, he announced that the 2025 Global Year theme will be Pain Management, Research and Education in Low- and Middle-income Settings. His other key initiatives as President include:

  • promoting environmental sustainability in pain research and care, and
  • setting ethical standards for the use of laboratory animals in pain research.

We congratulate Professor Rice on this prestigious appointment!

Peer Support. Join the community

“Having chronic pain is very lonely.”

Join the community

Subscribe to Pain Matters

Everything you need to know about how to live with chronic pain

Subscribe

 

 

In pain? Don’t understand what’s happening?

“Having someone to help you prepare for your life through pain”

Our Pain Education Sessions

Fundraise for Pain Concern

Help us to help others

Fundraise

 

A smiling John FInch receiving his Trustee of the Year Award

A joyous John Finch receiving his award for Trustee of the Year as part of Volunteers’ Week 2024

Celebrating Volunteers’ Week 2024: Honouring Our Outstanding Team

June was a month of celebration here at Pain Concern, as we’ve had the privilege of recognising some of our incredible volunteers and staff during Volunteers’ Week 2024. Their dedication and hard work have made a lasting impact on our community, and we couldn’t be more proud.

John Finch – Trustee of the Year

We are thrilled to announce that John Finch, one of our remarkable team members, has won the Trustee of the Year award for his exceptional contributions to Pain Concern.

Inspiring Volunteer Awards

In addition, the Inspiring Volunteer Awards at Edinburgh City Chambers honored Marjorie Fisher and Samantha Mason. A special highlight of the event was our founder and chief executive, Heather Wallace, receiving the Lord Provost’s Inspiring Volunteer of the Year award.

Heather’s inspiring engagement with health professionals has helped improve understanding and appreciation of the impacts of pain and related conditions and has had a profound impact on the latest Pain Education project.

Lord Provost Robert Aldridge

At Pain Concern, our work would not be possible without the dedication of incredible individuals like Heather, Samantha, John, and Marjorie. We are endlessly proud of our volunteers and staff. They offer their support in so many ways. Their efforts continue to forge a meaningful difference in the pain community.

Peer Support. Join the community

“Having chronic pain is very lonely.”

Join the community

Subscribe to Pain Matters

Everything you need to know about how to live with chronic pain

Subscribe

 

 

In pain? Don’t understand what’s happening?

“Having someone to help you prepare for your life through pain”

Our Pain Education Sessions

Fundraise for Pain Concern

Help us to help others

Fundraise

 

1 3 4 5 6 7 49